Status:
NOT_YET_RECRUITING
Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis
Lead Sponsor:
University of Health Sciences Lahore
Conditions:
Pneumothorax Spontaneous Primary
Pneumothorax Spontaneous Secondary
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
Pleural effusion is characterized by the accumulation of fluid in the pleural space, which typically contains about 10-20 mL of pleural fluid that is crucial for the movement of the lungs against the ...
Detailed Description
One of the most effective interventions for managing malignant pleural effusion (MPE) and pneumothoraces is chemical pleurodesis, which involves the introduction of a sclerosing agent into the pleural...
Eligibility Criteria
Inclusion
- patients aged 12 years and older.
- Diagnosed with malignant pleural effusions or pneumothoraces.
- ECOG performance status of 0-2.
- Life expectancy of at least 3 months.
- Ability to provide informed consent.
- No contraindications to general anesthesia or conscious sedation.
Exclusion
- Patients younger than 12 years old
- Female patients who are pregnant or lactating
- Patients with encysted or septated pleural effusions and pneumothoraces
- Patients presenting with respiratory failure
- Patients complaining of dyspnea in spite of complete evacuation of pleural effusion or pneumothorax.
- Patients with evident chest infection with clinical or laboratory signs suggestive of parapneumonic effusions.
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2027
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT07167992
Start Date
February 1 2026
End Date
March 30 2027
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Services Institute of Medical Sciences (SIMS), Services Hospital Lahore
Lahore, Punjab Province, Pakistan, 54000